Cardozo Timothy, Kimura Tetsuya, Philpott Sean, Weiser Barbara, Burger Harold, Zolla-Pazner Susan
Department of Pharmacology and New York University School of Medicine, New York, NY 10016, USA.
AIDS Res Hum Retroviruses. 2007 Mar;23(3):415-26. doi: 10.1089/aid.2006.0130.
The third variable region (V3) of the HIV-1 surface glycoprotein, gp120, plays a central role in the interaction of the virus envelope with the cell surface chemokine receptors, triggering membrane fusion and virus entry into human lymphocytes and macrophages. The CXCR4 and CCR5 chemokine receptors are used by "X4-tropic" and "R5-tropic" viruses, respectively. Recently, the crown of the V3 loop was shown to bear a close structural homology to the beta2-beta3 loop in the CXC and CC chemokines, the natural ligands of CXCR4 and CCR5, respectively. This homology can serve as the foundation for 3D molecular modeling of the V3 loops from primary isolates whose coreceptor usage was experimentally defined. The modeling revealed a charged "patch" on the surface of V3 that correlates with coreceptor usage. This V3 surface patch is positively charged in X4-tropic viruses and negatively charged or neutral in R5-tropic viruses, and is formed by two amino acids, at position 11 and at position 24 or 25; amino acids 11 and 24 or 11 and 25 contact each other in 3D space. Residues at positions 11 and 25 were known previously to influence coreceptor usage, and the charge of the residues at these two positions is often used to predict viral tropism. However, we found that the predictive value of using the charge of residues 11, 24, and 25 to identify X4 or R5 tropism was improved over using only the charge of residues 11 and 25. Thus, the data suggest a new " 11/24/25 rule" : a positively charged amino acid at position 11, 24, or 25 defines X4; otherwise R5. This rule gave an overall predictive value of 94% for 217 viruses whose tropism had been determined experimentally as either X4 or R5. The results have additional implications for the design of HIV therapeutics, vaccines, and strategies for monitoring disease progression.
人类免疫缺陷病毒1型(HIV-1)表面糖蛋白gp120的第三个可变区(V3)在病毒包膜与细胞表面趋化因子受体的相互作用中起核心作用,可触发膜融合以及病毒进入人类淋巴细胞和巨噬细胞。“X4嗜性”和“R5嗜性”病毒分别利用CXCR4和CCR5趋化因子受体。最近研究表明,V3环的顶部与CXC和CC趋化因子中的β2-β3环分别具有紧密的结构同源性,而CXCR4和CCR5的天然配体正是这些趋化因子。这种同源性可为通过实验确定共受体使用情况的原代分离株的V3环进行三维分子建模奠定基础。建模显示V3表面有一个与共受体使用情况相关的带电“区域”。在X4嗜性病毒中,这个V3表面区域带正电,而在R5嗜性病毒中带负电或呈中性,它由第11位以及第24或25位的两个氨基酸形成;在三维空间中,第11位氨基酸与第24位或第11位与第25位氨基酸相互接触。此前已知第11位和第25位的残基会影响共受体的使用情况,而且这两个位置残基的电荷常被用于预测病毒嗜性。然而,我们发现,相比于仅使用第11位和第25位残基的电荷,使用第11、24和25位残基的电荷来识别X4或R5嗜性的预测价值更高。因此,数据表明了一条新的“11/24/25规则”:第11、24或25位的带正电氨基酸定义为X4;否则为R5。对于217种嗜性已通过实验确定为X4或R5的病毒,该规则的总体预测价值为94%。这些结果对HIV治疗药物、疫苗的设计以及疾病进展监测策略具有额外的意义。